In Pharma-Factory, six different Plant
Molecular Farming platforms including whole plants, algae, hairy roots and
plant cell culture will be developed by SMEs working alongside academic
partners. These developments will lead to shortened production cycles and
increased product yields, and ultimately lower product cost to the end-users.
Plant Molecular Farming platforms provide unique opportunities as a result of specific features of the expression systems
The global market for bioengineered protein drugs was $172.5 billion in 2016 and it is expected to reach $228.4 billion by 2021.
![]()
View more details about the technology here︎
Plant Molecular Farming platforms provide unique opportunities as a result of specific features of the expression systems
The global market for bioengineered protein drugs was $172.5 billion in 2016 and it is expected to reach $228.4 billion by 2021.
View more details about the technology here︎
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 774078.
Pharma Factory copyright 2018
Terms of Service
Privacy Policy
Sitemap
Pharma Factory copyright 2018
Terms of Service
Privacy Policy
Sitemap